Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.
Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.
复制标题
DOI:
10.1182/blood.v106.11.723.723
复制
发表时间:
2005-10
期刊:
影响因子:
--
通讯作者:
D. Motto;A. Chauhan;Guojing Zhu;J. Homeister;Colin B. Lamb;K. Desch;Weirui Zhang;H. Tsai;D. Wagner;D. Ginsburg
中科院分区:
文献类型:
--
作者:
D. Motto;A. Chauhan;Guojing Zhu;J. Homeister;Colin B. Lamb;K. Desch;Weirui Zhang;H. Tsai;D. Wagner;D. Ginsburg
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening illness caused by deficiency of the vWF-cleaving protease ADAMTS13. Here we show that ADAMTS13-deficient mice are viable and exhibit normal survival, although vWF-mediated platelet-endothelial interactions are significantly prolonged. Introduction of the genetic background CASA/Rk (a mouse strain with elevated plasma vWF) resulted in the appearance of spontaneous thrombocytopenia in a subset of ADAMTS13-deficient mice and significantly decreased survival. Challenge of these mice with shigatoxin (derived from bacterial pathogens associated with the related human disease hemolytic uremic syndrome) resulted in a striking syndrome closely resembling human TTP. Surprisingly, no correlation was observed between plasma vWF level and severity of TTP, implying the existence of TTP-modifying genes distinct from vWF. These data suggest that microbe-derived toxins (or possibly other sources of endothelial injury), together with additional genetic susceptibility factors, are required to trigger TTP in the setting of ADAMTS13 deficiency.